Comparing Drospirenone and Norethindrone for Postpartum High Blood Pressure
This study is looking at two different progestin-only birth control pills, norethindrone and drospirenone, to see how well they help manage high blood pressure (hypertension) after delivery in women who had preeclampsia. Preeclampsia is a serious condition during pregnancy that causes high blood pressure. You might be able to join if you recently gave birth at Oregon Health & Science University (OHSU), had preeclampsia, and are thinking about using a progestin-only birth control pill. The main goal is to see how your blood pressure changes over six weeks after delivery while taking one of these medications. The study is currently unclear on its recruitment status and plans to enroll 50 participants.
- Study design
- This is an open-label, randomized study, meaning you and your doctors will know which medication you are taking. About 50 participants will be randomly assigned to receive either norethindrone or drospirenone.
- What's involved
- You would take one pill daily from hospital discharge until six weeks postpartum. You would also receive weekly emails to report medication use, home blood pressure readings, and any changes in your health or medications.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for six weeks after delivery to monitor their blood pressure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Julia Tasset · PRINCIPAL_INVESTIGATOR · Oregon Health and Science University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Blood PressureMeasured weekly for the 6 weeks following delivery.
Arterial, systolic, and diastolic blood pressure will be compared between norethindrone and drospirenone users. Measured by participants at home and reported in weekly surveys.